New heart mapping technique aims to stop Life-Threatening rhythms
NCT ID NCT06937983
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new method called decrement evoked potential (DeEP) mapping to guide catheter ablation for ventricular tachycardia (VT) in people with structural heart disease. VT is a fast, dangerous heart rhythm that can cause sudden cardiac arrest. The standard ablation procedure uses heat to destroy diseased heart tissue, but finding the exact trouble spots is often difficult. Researchers will enroll 77 adults with implantable defibrillators and use the DeEP mapping to target ablation more precisely. Patients will be followed for 12 months to see if this approach reduces VT episodes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
catheter ablation procedure guided by decrement evoked potential mapping
What this could lead to
If successful, this could make VT ablation more effective at preventing dangerous heart rhythm episodes, reducing the need for shocks from implantable defibrillators.
What could go wrong
This is a small, early-stage study (77 participants) testing a refined technique. The new mapping method may not improve outcomes over standard approaches, and ablation carries risks like bleeding, infection, or heart damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STRUCTURAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospitals Coventry & Warwickshire NHS Trust
RECRUITINGCoventry, West Midlands, CV2 2DX, United Kingdom